The cell surface marker CD34 characterizes a population enriched for HSCs, and the proportion of CD34+ cells found in the peripheral blood immediately after stroke has been found to directly correlate with functional recovery (Dunac et al., 2007). This evidence concerns the gene CD34 and Stroke.